Global Wheat Health Alliance

Wheat diseases are changing quickly.
The world cannot afford to fall behind.

The Global Wheat Health Alliance, or GWHA, is an international effort to drive the discovery, validation, and deployment of genes conferring durable resistance to the most destructive wheat diseases threatening food security among the world’s most vulnerable farming communities. GWHA is a core component of the Disease-Resistant Wheat Hybrids initiative, known as Hybread, which aims to develop the first disease-resistant, climate-resilient hybrid wheat varieties for smallholder farmers in Ethiopia and South Asia.

GWHA focuses on four major threats to wheat production: stem rust, yellow rust, wheat blast, and Fusarium head blight.

The Stakes

Wheat is the world’s second most widely cultivated crop, grown on over 220million hectares and providing a staple food source for billions of people. Approximately 25 percent of global wheat area lies within South Asia and Eastern Africa, producing 170 million tons annually. In these regions, rapidly evolving fungal diseases, including stem rust, yellow rust, wheat blast, and Fusarium head blight (FHB), are outpacing breeding efforts and threatening to undo decades of hard-won genetic gains.

The threat is not abstract. Stem rust races emerging from the East African highlands can render major resistance genes ineffective virtually overnight. Wheat blast, first identified in Brazil in 1985, has since jumped continents to Bangladesh and Zambia, with an estimated 7 million hectares in South Asia now considered vulnerable. FHB contaminates grain with deoxynivalenol (DON) mycotoxins, posing severe food safety risks, particularly for children. Climate change, shifting cropping systems, and expanding global trade are compounding these pressures.

The vulnerability is compounded by genetic uniformity. Nearly all wheat blast-resistant varieties deployed in South Asia rely on a single resistance locus, the 2NS translocation, which has already shown breakdown against newly emerged pathogen isolates in South America. For FHB, the most reliable resistance gene, Fhb1, has declined in frequency within elite breeding populations due to repulsive linkage with the widely used rust resistance gene Sr2. Without a diversified pipeline of new resistance sources, the world’s wheat crop faces compounding risk.

The GWHA operates through a coordinated four-stage pipeline that links gene discovery at Advanced Research Institutes (ARIs) to variety deployment by National Agricultural Research Systems (NARS):

Identify new resistance. Through a network of Precision Phenotyping Platforms (PPPs) in disease hotspots across Kenya, Mexico, Bolivia, Bangladesh, and Ethiopia, the GWHA evaluates thousands of wheat lines under severe disease pressure. Elite breeding material, genetic resources, and ARI-developed genetic stocks are screened and validated under real-world field conditions.

Harness research innovation. Partner laboratories contribute novel resistance genes from wheat wild relatives, mapped susceptibility factors that can be targeted through gene editing, and molecular markers (including KASP markers) that allow breeders to track resistance genes at scale. Innovations span all target diseases and include both conventional introgression and genome editing strategies.

Accelerate breeding pipelines. Validated resistance sources are incorporated into CIMMYT’s pre-breeding programs and international nursery distribution system, reaching breeding programs worldwide. Marker-assisted selection, speed breeding, and quantitative genetics compress the timeline from gene discovery to resistant varieties in farmers’ fields.

Build the next generation. Drawing on the BGRI’s established platforms and networks at Cornell University, the GWHA invests in durable human capital through hybrid training modules, hands-on technical trainings, a global community of practice, and targeted capacity building at major international conferences.

Over the three-year investment period, GWHA targets the following measurable outcomes:

• Fusarium head blight: At least 10 wheat lines carrying three or more stacked resistance genes for enhanced FHB and DON resistance, along with new molecular markers for efficient marker-assisted selection. Additionally, at least three wheat lines introgressed with edited genes from ARI partners for enhanced FHB resistance.
• Wheat blast: At least 10 wheat lines carrying three or more genes for enhanced blast resistance, plus validated molecular markers for new resistance loci and functionally validated candidate genes from the 2NS region.
• Wheat rusts: Validated adult-plant resistance gene combinations effective under high disease pressure, refined KASP and linked markers for Yr15 and diverse yellow rust and stem rust loci, and CIMMYT elite breeding lines carrying stacked rust resistance genes tested across international nurseries.
• Phenotyping and data: A comprehensive database of disease scores from germplasm tested across PPPs, covering approximately 2,000 lines for FHB, 2,000 for wheat blast, and 4,000 for stem rust and yellow rust resistance.
• Human capital: At least 100 NARS and ARI scientists trained in wheat pathology experimental techniques, disease phenotyping, and disease resistance breeding.

The Disease-Resistant Wheat Hybrids investment, or HyBread, is a three-year initiative led by CIMMYT and funded by the Gates Foundation and the United Kingdom’s Foreign, Commonwealth & Development Office (FCD). The investment aims to develop the first disease-resistant, climate-resilient hybrid wheat varieties for smallholder farmers in Ethiopia and South Asia, leveraging a novel blue aleurone (BLA) male-sterility system developed by the University of Sydney and KWS.

The project is structured across three integrated work packages:

1. Work Package 1 (Pure Line Development)
2. Work Package 2 (Hybrid Development)
3. Work Package 3 (the Global Wheat Health Alliance)